Hearing Loss Management in Children: Guidelines and Interventions
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Pediatrics".
Deadline for manuscript submissions: 25 July 2026 | Viewed by 1
Special Issue Editor
Interests: pediatric audiology; outcome data; intervention studies
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Introduction of universal neonatal hearing screening, early diagnosis of hearing loss (HL), and early intervention with hearing technology—hearing aids (HAs) and cochlear implants (CIs)—combined with specific educational intervention has markedly changed life conditions for children with HL. Children with HL are an ongoing clinical concern, and it has been documented that medical, surgical, technical, and educational interventions have allowed children and adolescents with HL to achieve outcomes of audition, language, and social well-being never before documented for the population. It is, however, important to recognise that even though HL is treated with state-of-the-art hearing technology, children with HL do not have normal hearing (NH). Distance to the sound signal and background noise are still challenging for children and adolescents with HL. Therefore, it is of the utmost importance to bring together updated knowledge on emerging new approaches, with a specific focus on how challenges are solved around the globe.
This Special Issue aims to provide information on studies that focus on timely and relevant interventions for new generations with HL.
Prof. Dr. Lone Percy-Smith
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- early intervention for populations with HL
- emerging new generations of persons with HL
- quality assurance of interventions for populations with HL
- self-assessments of quality of life
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
